Charles Pauling Semba

Insider Reports History

Location
Two Carlson Parkway, Suite 260, Minneapolis, MN
Signature
/s/ Scott Kellen, attorney-in-fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Charles Pauling Semba:

Stock Role Class Num Shares Value Price $ Report Date Ownership
DiaMedica Therapeutics Inc. Director Voting Common Shares, no par value per share 44.6K $165K $3.69 Jun 1, 2025 Direct
DiaMedica Therapeutics Inc. Director Voting Common Shares, no par value per share 39.3K $110K $2.80 Jun 1, 2024 Direct
DiaMedica Therapeutics Inc. Director Stock Option (right to buy) 32.2K Jun 1, 2025 Direct

Insider Reports Filed by Charles Pauling Semba

Symbol Company Period Transactions Value $ Form Type Date Filed Role
DMAC DiaMedica Therapeutics Inc. Jun 1, 2025 1 $0 4 Jun 3, 2025 Director
DMAC DiaMedica Therapeutics Inc. Jan 2, 2025 1 $28.2K 4 Jan 3, 2025 Director
DMAC DiaMedica Therapeutics Inc. Jun 1, 2024 1 $0 4 Jun 3, 2024 Director
DMAC DiaMedica Therapeutics Inc. Jan 2, 2024 1 $26.3K 4 Jan 2, 2024 Director
DMAC DiaMedica Therapeutics Inc. Jun 23, 2023 1 $50K 4 Jun 26, 2023 Director
DMAC DiaMedica Therapeutics Inc. Jun 1, 2023 1 $0 4 Jun 2, 2023 Director
DMAC DiaMedica Therapeutics Inc. Jan 3, 2023 1 $26.2K 4 Jan 3, 2023 Director
DMAC DiaMedica Therapeutics Inc. Jun 1, 2022 1 $0 4 Jun 2, 2022 Director
DMAC DiaMedica Therapeutics Inc. Jul 15, 2021 1 $0 4 Jul 16, 2021 Director
DMAC DiaMedica Therapeutics Inc. Jul 15, 2021 0 $0 3 Jul 16, 2021 Director